Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

992 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gastric MALT Lymphoma: A 8-Year Experience.
Couto ME, Oliveira I, Domingues N, Viterbo L, Martins Â, Moreira I, Espírito Santo A, Chacim S, Moreira C, Pereira D, Henrique R, Mariz J. Couto ME, et al. Among authors: moreira c, moreira i. Indian J Hematol Blood Transfus. 2022 Jul;38(3):492-498. doi: 10.1007/s12288-021-01483-0. Epub 2021 Aug 26. Indian J Hematol Blood Transfus. 2022. PMID: 35747568 Free PMC article.
Gastric Diffuse Large B-Cell Lymphoma: A Single-Center 9-Year Experience.
Couto ME, Oliveira I, Domingues N, Viterbo L, Martins Â, Moreira I, Espírito-Santo A, Chacim S, Moreira C, Pereira D, Henrique R, Mariz J. Couto ME, et al. Among authors: moreira c, moreira i. Indian J Hematol Blood Transfus. 2021 Jul;37(3):492-496. doi: 10.1007/s12288-020-01391-9. Epub 2021 Jan 2. Indian J Hematol Blood Transfus. 2021. PMID: 33424149 Free PMC article.
Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia.
ESPíRITO Santo AE, Chacim S, Ferreira I, Leite L, Moreira C, Pereira D, Dantas Brito MD, Nunes M, Domingues N, Oliveira I, Moreira I, Martins A, Viterbo L, Mariz JM, Medeiros R. ESPíRITO Santo AE, et al. Among authors: moreira c, moreira i. Oncol Lett. 2016 Jul;12(1):262-268. doi: 10.3892/ol.2016.4591. Epub 2016 May 17. Oncol Lett. 2016. PMID: 27347135 Free PMC article.
Southwestern Oncology Group pretreatment risk criteria as predictive or prognostic factors in acute myeloid leukemia.
Espirito Santo A, Chacim S, Ferreira I, Leite L, Moreira C, Pereira D, Dantas M, Nunes M, Viterbo L, Moreira I, Martins A, Oliveira I, Domingues N, Mariz J, Medeiros R. Espirito Santo A, et al. Among authors: moreira c, moreira i. Mol Clin Oncol. 2017 Mar;6(3):384-388. doi: 10.3892/mco.2017.1134. Epub 2017 Jan 20. Mol Clin Oncol. 2017. PMID: 28451418 Free PMC article.
Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution.
Cerveira N, Loureiro B, Bizarro S, Correia C, Torres L, Lisboa S, Vieira J, Santos R, Pereira D, Moreira C, Chacim S, Domingues N, Espírito-Santo A, Oliveira I, Moreira I, Viterbo L, Martins Â, Teixeira MR, Mariz JM. Cerveira N, et al. Among authors: moreira c, moreira i. BMC Cancer. 2018 Dec 12;18(1):1245. doi: 10.1186/s12885-018-5167-y. BMC Cancer. 2018. PMID: 30541488 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 33947644
Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.
Cerveira N, Lisboa S, Correia C, Bizarro S, Santos J, Torres L, Vieira J, Barros-Silva JD, Pereira D, Moreira C, Meyer C, Oliva T, Moreira I, Martins Â, Viterbo L, Costa V, Marschalek R, Pinto A, Mariz JM, Teixeira MR. Cerveira N, et al. Among authors: moreira c, moreira i. Mol Oncol. 2012 Oct;6(5):553-64. doi: 10.1016/j.molonc.2012.06.004. Epub 2012 Jul 14. Mol Oncol. 2012. PMID: 22846743 Free PMC article.
Semiquantitative analysis of interim 18F-FDG PET is superior in predicting outcome in Hodgkin lymphoma patients compared to visual analysis.
Ribeiro T, Marques A, Ferreira G, Castro C, Tavares M, Espírito-Santo A, Moreira C, Mariz J. Ribeiro T, et al. Among authors: moreira c. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 Sep-Oct;40(5):281-286. doi: 10.1016/j.remnie.2020.06.016. Epub 2020 Dec 3. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021. PMID: 34425968
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma.
Leonard JP, Trneny M, Izutsu K, Fowler NH, Hong X, Zhu J, Zhang H, Offner F, Scheliga A, Nowakowski GS, Pinto A, Re F, Fogliatto LM, Scheinberg P, Flinn IW, Moreira C, Cabeçadas J, Liu D, Kalambakas S, Fustier P, Wu C, Gribben JG; AUGMENT Trial Investigators. Leonard JP, et al. Among authors: moreira c. J Clin Oncol. 2019 May 10;37(14):1188-1199. doi: 10.1200/JCO.19.00010. Epub 2019 Mar 21. J Clin Oncol. 2019. PMID: 30897038 Free PMC article. Clinical Trial.
992 results